These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17508277)

  • 1. Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.
    Mazumder R; Hu ZZ; Vinayaka CR; Sagripanti JL; Frost SD; Kosakovsky Pond SL; Wu CH
    Virus Genes; 2007 Oct; 35(2):175-86. PubMed ID: 17508277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.
    Muthusamy K; Gopinath K; Nandhini D
    Indian J Med Res; 2016 Oct; 144(4):587-591. PubMed ID: 28256468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
    Hussain M; Idrees M; Afzal S
    Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody.
    Lok SM; Ng ML; Aaskov J
    J Med Virol; 2001 Oct; 65(2):315-23. PubMed ID: 11536239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans.
    Fleith RC; Lobo FP; Dos Santos PF; Rocha MM; Bordignon J; Strottmann DM; Patricio DO; Pavanelli WR; Lo Sarzi M; Santos CN; Ferguson BJ; Mansur DS
    Sci Rep; 2016 Nov; 6():36339. PubMed ID: 27805018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of amino acids in the dengue virus type 2 envelope glycoprotein critical to virus infectivity.
    Kroschewski H; Sagripanti JL; Davidson AD
    J Gen Virol; 2009 Oct; 90(Pt 10):2457-2461. PubMed ID: 19587132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
    Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
    Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design.
    Li XQ; Qiu LW; Chen Y; Wen K; Cai JP; Chen J; Pan YX; Li J; Hu DM; Huang YF; Liu LD; Ding XX; Guo YH; Che XY
    J Gen Virol; 2013 Oct; 94(Pt 10):2191-2201. PubMed ID: 23851440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
    Hughes HR; Crill WD; Davis BS; Chang GJ
    Virology; 2012 Mar; 424(2):129-37. PubMed ID: 22244913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.
    Rocha RP; Livonesi MC; Fumagalli MJ; Rodrigues NF; da Costa LC; Dos Santos MC; de Oliveira Rocha ES; Kroon EG; Malaquias LC; Coelho LF
    Virus Res; 2014 Aug; 188():122-7. PubMed ID: 24768848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence.
    Sun J; Li M; Wang Y; Hao P; Jin X
    Vaccine; 2017 Nov; 35(46):6308-6320. PubMed ID: 28987441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
    Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity.
    Leng CH; Liu SJ; Tsai JP; Li YS; Chen MY; Liu HH; Lien SP; Yueh A; Hsiao KN; Lai LW; Liu FC; Chong P; Chen HW
    Microbes Infect; 2009 Feb; 11(2):288-95. PubMed ID: 19114121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.
    Verma M; Bhatnagar S; Kumari K; Mittal N; Sukhralia S; Gopirajan At S; Dhanaraj PS; Lal R
    Gene; 2019 May; 695():18-25. PubMed ID: 30738967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
    Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
    BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination.
    Slon Campos JL; Poggianella M; Marchese S; Bestagno M; Burrone OR
    J Gen Virol; 2015 Nov; 96(11):3265-3279. PubMed ID: 26358704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.